MedPath

The Effect of Holy Qur’an Recitation on the inflammatory factors

Not Applicable
Recruiting
Conditions
Chronic Kidney Disease.
Chronic kidney disease, stage 5
N18.5
Registration Number
IRCT20120109008665N9
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Willingness to listen to the Holly Quran
Consent to participate in the study
Age range 20 to 65 years
At least six months of treatment with hemodialysis
Consciousness
having hemodynamic stability
No history of recent infection (recent 3 months)
The lack of serious psychiatric problems
Obtain Score 10 for the anxiety and 7 for the depression items of the Hospital Anxiety and Depression Scale (HADS)
No history of long-term use of corticosteroids and immunosuppressive drugs

Exclusion Criteria

left handed
Hearing impairment
Reciter of Quran
Arabic speaking patients

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of the inflammatory factor (IL6). Timepoint: Before intervention and one month later. Method of measurement: Using an ELISA kit for measuring human IL-6, product of Diaclone France.;Level of the inflammatory factor (Erythrocyte Sedimentation Rate). Timepoint: Before intervention and one month later. Method of measurement: ESR measurement using ESR tube containing sodium citrate solution, Product of Teb Shahr Company.;Level of the inflammatory factor (C Reactive Protein). Timepoint: Before intervention and one month later. Method of measurement: CRP measurement, using ELISA, Using the XL Selectra device, a product from the Netherlands.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath